Literature DB >> 7093093

Role of labetalol in acute myocardial infarction.

A D Timmis, M B Fowler, N S Jaggarao, R Vincent, D A Chamberlain.   

Abstract

1 The role of labetalol in managing acute myocardial infarction is reviewed. 2 After intravenous infusion labetalol lowers blood pressure in patients with increased blood pressure associated with acute myocardial infarction. 3 Although average heart rate was decreased, cardiac index fell only slightly and stroke index was substantially unchanged. 4 In patients whose pretreatment pulmonary artery end-diastolic pressures were increased, labetalol induced decreases, whereas in the presence of normal pressures, these were unchanged. 5 It is concluded that labetalol infusion in patients with acute myocardial infarction is unlikely to precipitate heart failure and is likely to be of value in reducing myocardial oxygen requirement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093093      PMCID: PMC1401843          DOI: 10.1111/j.1365-2125.1982.tb01898.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  The reduction of infarct size--an idea whose time (for testing) has come.

Authors:  E Braunwald; P R Maroko
Journal:  Circulation       Date:  1974-08       Impact factor: 29.690

2.  Velocity of contraction as a determinant of myocardial oxygen consumption.

Authors:  E H Sonnenblick; J Ross; J W Covell; G A Kaiser; E Braunwald
Journal:  Am J Physiol       Date:  1965-11

3.  Reduction of enzyme levels by propranolol after acute myocardial infarction.

Authors:  T Peter; R M Norris; E D Clarke; M K Heng; B N Singh; B Williams; D R Howell; P K Ambler
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

4.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Labetalol infusion in acute myocardial infarction with systemic hypertension.

Authors:  P G Marx; D S Reid
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina.

Authors:  A Maseri; A L'Abbate; G Baroldi; S Chierchia; M Marzilli; A M Ballestra; S Severi; O Parodi; A Biagini; A Distante; A Pesola
Journal:  N Engl J Med       Date:  1978-12-07       Impact factor: 91.245

7.  Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.

Authors:  S Yusuf; D Ramsdale; R Peto; L Furse; D Bennett; C Bray; P Sleight
Journal:  Lancet       Date:  1980-08-09       Impact factor: 79.321

  7 in total
  2 in total

1.  Labetalol: the nineteen-eighties.

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 2.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.